21st Austria weekly - Agrana (12/05/2026)

Agrana: AGRANA Beteiligungs-AG, an internationally-oriented industrial company that adds value to agricultural commodities, announced the final results for the 2025|26 financial year. While the Group’s revenue decreased by 7.9% to € 3,237.3 million in the 2025|26 financial year, operating profit before exceptional items and results of equity-accounted joint ventures rose by 6.2% to € 81.2 million (previous year: € 76.5 million). Exceptional items amounted to a net expense of € 74.1 million (previous year: net expense of € 36.4 million) and included a non-cash impairment charge of € 46.0 million on non-current assets in the ACS – Sugar segment. This write-down had a strong negative impact on Group operating profit (EBIT), which fell to just € 3.2 million (previous year: € 40.5 million). CEO Stephan Büttner: “For the new financial year now underway, we expect the earnings KPI “operating profit before exceptionals and joint ventures” to remain at least stable, together with a projected very significant improvement in EBIT. We have set the right course: Our optimism is based on our operational performance, our diversified business model and the structural transformation at the holding company and segment levels under the Agrana Next Level Group strategy.”
Agrana: weekly performance: 0.85%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (12/05/2026)

Christian Drastil: Wiener Börse Plausch

Börsepeople im Podcast S25/01: Christian Drastil (Plan CD)

Bildnachweis

1. Agrana kauft Toppings- und Fillings-Spezialisten Mercator-Emba, Fotoquelle: Agrana , (© Aussender)   >> Öffnen auf photaq.com

Aktien auf dem Radar:Frequentis, Agrana, Bajaj Mobility AG, EuroTeleSites AG, Amag, UBM, FACC, OMV, Verbund, Porr, Rosgix, EVN, AT&S, Rosenbauer, voestalpine, Wienerberger, Wolford, Wolftank-Adisa, BKS Bank Stamm, Oberbank AG Stamm, CPI Europe AG, Österreichische Post, Semperit, Telekom Austria, RHI Magnesita, DAX, Siemens, HeidelbergCement, MTU Aero Engines, Henkel, Fresenius Medical Care.

Random Partner

---

Marinomed
Marinomed hat die Vision, das Leben von Patienten, die an Krankheiten mit unzureichenden Behandlungsmöglichkeiten leiden, in zwei wichtigen therapeutischen Bereichen nachhaltig zu verbessern: Virologie und Immunologie.

>> Besuchen Sie 55 weitere Partner auf boerse-social.com/partner